ESSENTIAL CARE AFTER AN IN-PATIENT FALL
|
|
- Stephanie Hensley
- 5 years ago
- Views:
Transcription
1 ESSENTIAL CARE AFTER AN IN-PATIENT FALL In line with the National Patient Safety Agency Rapid Response Report (NPSA/2011/RRR001): Essential care after an inpatient fall, in caring for a patient who has fallen, we have a responsibility not only to detect and treat the consequences of a fall, but its causes. In hospital patients, falls can be an indication of serious underlying illness. Nursing staff will normally be first to respond to a fall. Involvement of the appropriate medical staff must be on the basis of need, as outlined below. If medical staff or emergency services are contacted, the nurse must be clear on the area of concern and use SBAR to ensure effective communication. Immediate Safety 1. Assess patient, utilising an ABCDE approach, if acute life threatening medical emergency activate the emergency response system Ensure a full patient assessment and observations are carried out (in line with your training). Check blood glucose level using near patient testing and document all appropriate information on a FEWS chart. 3. Address any urgent problems (e.g. compromised airway, breathing difficulty, circulation/bleeding). 4. Patient must be clinically assessed for any signs of injury, including symptoms of fracture, head injury or potential spinal injury before being moved. 5. If a head injury is suspected or cannot be excluded, neurological observations must be undertaken in line with SIGN Guideline-110; Early Management Of Patients With A Head Injury and urgent medical advice sought (Appendix 1) 6. If any injuries noted, then appropriate referral must take place (e.g. medical staff or emergency services) N.B. special equipment e.g. hard collars, flat-lifting equipment, scoops may be required before moving the patient. 7. If the patient presents with signs and symptoms of a suspected fracture (e.g. severe pain; loss of sensation; absent distal pulse; limb in unnatural position) do not move the patientmake the patient comfortable on the floor and contact medical staff for advice and guidance. 8. If there is no sign of injury, including symptoms of fracture, head injury or potential spinal injury, assist the patient back to bed or chair as appropriate, following safe manual handling methods. For all but the most agile patients, hoists are likely to be required following a fall to the floor. Where patients are unable to get themselves off the floor independently, they will require to be hoisted. Where patients have sustained a fracture, in particular to the neck of femur, they will be required to be flat lifted. Staff must familiarise themselves with the location of the nearest available flat lifter so it can be utilised when required. Author: Essential Care After an Inpatient Fall SLWG Page 1 of 5 Review date: n/a
2 Treating minor injuries Nursing staff must use their clinical judgement, in the treatment of minor injures. These may include bruising; grazes and skin tears but should not hesitate to inform medical staff if they require further advice and guidance. Informing Relatives 1. The patient s next of kin / carers should be informed of the fall. a) When a patient falls and suffers significant injury (e.g. fracture) their next of kin would be contacted as soon as possible. b) For a fall with minor injury, their next of kin should be informed during normal working hours. If the patient falls during the night, they should be contacted the next morning. c) For a fall with no apparent injury, their next of kin must be informed when they next visit or telephone the ward. d) Where there is no close relative, staff should use their judgement, considering the closeness of the relationship between the patient and their most significant relative/friend. (e.g. if next of kin. is a neighbour who frequently visits patient, inform them of fall, but if next of kin is a second cousin in USA, it may not be appropriate). e) If the patient is a frequent faller, relative s preferences about phone calls subsequent to a fall (e.g. no night calls) should be discussed in advance and recorded next to their telephone number in the nursing notes. Aftercare 1. Document the circumstance surrounding the fall and action taken to reduce further falls and inform the appropriate line manager if any severe injury has been sustained. 2. Ensure that the clients handling risk assessment form is updated to reflect any changes in manual handling requirements 3. Reassess the patient using NHS Fife Falls Risk Assessment. If no extrinsic factor can be associated with a fall, medical advice and review including current medication (Appendix 2) must be sought to rule out any pathophysiological or any other contributing factors. 4. A NHS Fife Incident Report Form (IR1) must be completed following a fall or near miss as soon as possible after the incident. 5. Following a fall that results in major or extreme harm to a patient, senior management must be informed. An investigation will be undertaken by the senior management using the rapid event investigation tool (incorporated in falls and bone health toolkit) 6. Educate patient /carer in falls prevention. Author: Essential Care After an Inpatient Fall SLWG Page 2 of 5 Review date: n/a
3 Action Plan Patient must be clinically assessed for any signs of injury, including symptoms of fracture, head injury or potential spinal injury before being moved. If any injuries noted then appropriate referral must take place. This must be documented in the patients notes Safe manual handling methods must be used for patients with signs and symptoms of fracture, head injury or potential spinal injury, including the use of special equipment The frequency of neurological observations for all patients where a head injury has occurred, or cannot be excluded, are carried out in line with SIGN guideline 110 Early Management of Patients with a Head Injury Document the circumstance surrounding the fall and action taken to reduce further falls and inform the appropriate line manager Medical Staff N.B. Medical staff must review the patient s medication (Appendix2) Patient reassessed using NHS Fife Falls Risk Assessment The Patients next of kin/carer should be informed Advice and guidance can be sought from medical staff and where appropriate or emergency services Complete NHS Fife Incident Report Form Following a fall that results in major or extreme harm to a patient, the senior management must be informed. An investigation will be undertaken by senior management using the rapid event investigation tool. Author: Essential Care After an Inpatient Fall SLWG Page 3 of 5 Review date: n/a
4 The Glasgow Coma Scale (GCS) and Score Appendix 1 Management Plans: ½ hours clinical observations including GCS for first 2 hours or if GCS less than 15.* 1 hourly clinical observations including GCS for next 4 hours. 2 hourly clinical observations including GCS for next 6 hours. 4 hourly clinical observations including GCS until medical advice dictates otherwise. Nursing staff to call for a medical review if: o Development of agitation or altered behaviour. o Any decrease in GSC of one point o Development of severe or increasing headache or persistent vomiting. o New or evolving neurological symptoms and signs. For further information please refer to NHS Fife JBI Nursing Procedure Manual (on the NHS Fife intranet) and SIGN 110 Feature Scale Responses Score Notation Eye opening Spontaneous 4 To speech 3 To pain 2 Verbal response Orientated 5 Confused conversation 4 Words (inappropriate) 3 Sounds (incomprehensible) 2 Best motor response TOTAL COMA SCORE Obey commands 6 Localise pain 5 Flexion Normal 4 Abnormal 3 Extend 2 3/15 15/15 * NB: It is essential when interpreting clinical observations, including the GCS, to take into account any underlying health condition prior to the suspected head injury (e.g. Dementia) Author: Essential Care After an Inpatient Fall SLWG Page 4 of 5 Review date: n/a
5 Appendix 2 Commonly Prescribed Drugs that May Contribute to Falls This list has been based upon a review of the clinical evidence of medicines implicated in falls, including the most commonly used drugs with side effect associated with an increase in falls risk. The list is not meant to be fully comprehensive but intended to raise awareness of the types of drugs that can contribute to falls. Drugs have been graded as either a high, moderate or low risk in terms of their potential to cause falls. HIGH RISK DRUGS Antidepressants Antipsychotics including atypicals Avoid Tricyclic antidepressants esp TCAs with high anti-muscarinic activity eg Amitriptyline. SSRIs are associated with a reduced incidence of side effects in the elderly. Trial of gradual withdrawal should beattempted for all anti-depressants after 6 12 months of initial treatment. Risk of hypotension is a dose related effect reduced by the start low go slow approach. ttemptedwithdrawal MUST always be gradual to avoid precipitation of withdrawal symptoms e.g. rebound agitationetc. All antipyschotics are capable of inducing extra-pyramidal disorders although incidence is less withatypicals. The phenothiazine Prochlorperazine (Stemetil) is frequently inappropriately prescribed fordizziness due to postural instability and the most frequently implicated drug causing drug induced Parkinson s disease. Anti-muscarinic drugs (Anticholinergics) Benzodiazepines & Hypnotics Dopaminergic drugs used in Parkinsons disease Anti-muscarinic drugs are used in treatment of urinary incontinence and in Parkinson s disease. Oxybutyninmay cause acute confusional states in the elderly especially those with pre-existing cognitive impairment. Whilst complete withdrawal may not be an achievable goal there is still benefit to be gained in reducing useto the minimum effective dose. (Ref BNF). Avoid long acting benzodiazepines e.g, Nitrazepam. Newerhypnotics e.g. Zopiclone are associated with reduced hangover effects but all licensed for short-term use only. Sudden excessive daytime sleepiness can occur with Levodopa and other dopamine receptor agonists. Careful dose titration is particularly important in initiation of treatment because of additional risk of inducing confusion. As the patient ages, maintenance doses may need to be reduced. MODERATE RISK DRUGS ACE inhibitors / Angiotensin II antagonists Alpha blockers Anti-arrhythmics Anti-histamines Beta-blockers Diuretics Opiate analgesics LOW RISK DRUGS Calcium Channel Blockers Nitrates Oral anti-diabetic drugs Proton Pump Inhibitors (PPIs) & H2 Antagonists Risk of hypotension is potentiated by concomitant diuretic use. Incidence of dizziness varies from 4-12% of patients but affects twice as many patients with heart failure than hypertension. Doses used for treatment of BPH less likely to cause hypotension than those required to treat hypertension. Dizziness and drowsiness are possible signs of Digoxin toxicity risks of toxicity greater in renal impairmentor in the presence of hypokalaemia. Flecainide has a high risk for drug interactions and can also cause dizziness. Somnolence may affect up-to 40% of patients with older antihistamines e.g. Chlorpheniramine. The neweranti-histamines e.g. Desloratidine cause less sedation and psychomotor impairment. Risk of hypotension with Cinnarizine is a dose related side effect. Reports of dizziness may be due to postural hypotension and can affect up to 10% of patients. Water-solublebeta-blockers can accumulate in renal impairment and therefore dose reduction is often necessary. Postural hypotension, dizziness and nocturia are the most frequent problems seen in the elderly. Diuretics should not be prescribed for long-term use in the treatment of gravitational oedema. Drowsiness and sedation common with initiation of treatment but tolerance to these side effects is usually seen within 2 weeks of continuous treatment. Drowsiness and sedation is rare with Codeine unlessconcurrently used in combination with other drugs with CNS effects. Confusion also reported with Tramadol. Incidence dizziness low especially for once daily dihydropyridone calcium channel blockers e.g. Felodipine Dizziness may be due to postural hypotension. Advise patient to sit when using GTN spray or tablets. Dizziness due to hypoglycaemia but usually avoidable. Avoid long acting sulphonylureas e.g.chlorpropamide. Avoid Cimetidine in polypharmacy patients high risk of potential drug interactions. Cimetidine alsoassociated with causing confusion in the elderly. Reports of dizziness, somnolence are uncommon andmental confusion or blurred vision rare with the other PPIs and H2 antagonists. Adapted from: (Accessed 11th August 2011) Author: Essential Care After an Inpatient Fall SLWG Page 5 of 5 Review date: n/a
STOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationFalls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in
This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationPolypharmacy: Guidance for Prescribing in Frail Adults
Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationIntroductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs
Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available
More informationPrescribing Framework for Galantamine in the Treatment and Management of Dementia
Hull & East Riding Prescribing Committee Prescribing Framework for Galantamine in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker)
More informationSmoking Cessation Pharmacotherapy Guidelines
Smoking Cessation Pharmacotherapy Guidelines INTRODUCTION This guideline is based on public health guidance 10 Smoking Cessation Services issued by the National Institute for Health and Clinical Excellence
More informationCLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES
National Patient Safety Alert RRR018 Preventing Fatalities From Medication Loading Doses (November 2010) MMCP05 CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES INTRODUCTION
More informationCLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES
National Patient Safety Alert RRR018 Preventing Fatalities From Medication Loading Doses (November 2010) CP11 CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES INTRODUCTION The
More informationspontaneous localises pain withdraws to pain abnormal flexion abnormal extension none > 5 years 2 5 years 0 2 years
APPENDIX. GLASGOW COMA SCALES (GCS) For Adults Alert patients have a total score of 5 Eye Opening: to voice to pain Verbal Score: 5 oriented confused but answers questions inappropriate words: recognises
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationPrescribing Framework for Rivastigmine in the Treatment and Management of Dementia
Hull & East Riding Prescribing Committee Prescribing Framework for Rivastigmine in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker)
More informationConduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA)
E102 Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA) Patient details Name: Date of birth: NHS number: Contact details Specialist:
More informationNeuropathic Pain Treatment Guidelines
Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,
More informationIntelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork
Intelligent Polypharmacy Professor Colin P Bradley Department of General Practice University College Cork Polypharmacy No standard definition 2005 review the use of medications that are not clinically
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationFalls Prevention Best Practice
Falls Prevention Best Practice Prepared by Denise Tomassini Falls Prevention A case study : Mr Tony Topples ISLHD Clinical Quality Manager Clinical Governance Unit November 2011 Falls Prevention Best Practice
More informationGeri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationEffective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go )
Effective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go ) This shared care agreement outlines the ways in which the responsibilities
More informationEuropean PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam
European PSUR Work Sharing Project CORE SAFETY PROFILE Lendormin, 0.25mg, tablets Brotizolam 4.2 Posology and method of administration Unless otherwise prescribed by the physician, the following dosages
More informationBest Practice Guidelines BPG 8 Management and Prevention of Falls
Best Practice Guidelines BPG 8 Management and Prevention of Falls 1 Version 3 draft Sept 2015 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationInitiation of Clozapine Treatment Community Patients
Initiation of Clozapine Treatment Community Patients Who Should Read This Policy Target Audience All clinical staff working in the community N/A N/A Initiation of Clozapine Treatment for Patients in the
More informationPrimary Care Prescribing Protocol to Support the Diagnosis and Management of People with Dementia
Primary Care Prescribing Protocol to Support the Diagnosis and Management of People with Dementia This prescribing guideline provides the necessary information and guidance to support clinicians in the
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationMedications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy
Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationMMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA
MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA Page 1 of 11 Table of Contents Why we need this Guideline... 3 What the Policy is trying to do... 3 Which stakeholders have been
More informationANAESTHESIA & PAIN MANAGEMENT FOR KNEE REPLACEMENT
BEFORE SURGERY ANAESTHESIA & PAIN MANAGEMENT FOR KNEE REPLACEMENT FASTING INSTRUCTIONS No food for 6 hours before your operation. It is okay to drink clear fluids up to 2 hours before surgery (water, clear
More informationLower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital
Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of
More informationLOSS OF CONSCIOUSNESS & ASSESSMENT. Sheba Medical Center Acute Medicine Department MATTHEW WRIGHT
LOSS OF CONSCIOUSNESS & ASSESSMENT Sheba Medical Center Acute Medicine Department MATTHEW WRIGHT OUTLINE Causes Head Injury Clinical Features Complications Rapid Assessment Glasgow Coma Scale Classification
More informationSUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS
SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS Guideline Title Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics Legislative basis Directive
More informationPatient Group Direction for PROCHLORPERAZINE (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationM0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:
M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered
More informationSummary of Delirium Clinical Practice Guideline Recommendations Post Operative
Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;
More informationInformation leaflet for primary care: Agomelatine
Information leaflet for primary care: Agomelatine Background information Agomelatine is an antidepressant indicated for the treatment of major depressive episodes in adults. Agomelatine is a melatonin
More informationAppendix 2: Admissions checklists for people with Parkinson s
Appendix 2: Admissions checklists for people with Parkinson s This document is intended to form the basis of a locally developed tool and so it has been built to be amended with relevant local information,
More informationPharmaceutical Care for Geriatrics
Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationFalls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34
SECTION: 1 PATIENT CARE Including Physical Healthcare POLICY /PROCEDURE: 1.34 NATURE AND SCOPE: SUBJECT (Title): POLICY AND PROCEDURE - TRUST WIDE FALLS: THE ASSESSMENT, PREVENTION AND MANAGEMENT OF PATIENT
More informationDrug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression
SHARED CARE PROTOCOL AND INFORMATION FOR GPS Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression Version:
More informationSIFROL â. Contraindications Hypersensitivity to pramipexole or any other component of the product.
SIFROL â Composition 1 tablet contains 0.088, 0.18 & 0.7 mg (S) 2 amino 4,5,6,7-tetrahydro-6-propylamino-benzothiazole (= pramipexole base) equivalent to 0.125, 0.25 & 1 mg of pramipexole dihydrochloride
More informationSHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE
SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE INDICATION Naltrexone is a pure opiate antagonist licensed as an adjunctive prophylactic therapy in the maintenance
More informationPOLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy
POLICY DOCUMENT Document Title Reference Number PRESCRIBING FOR PAIN MANAGEMENT IN OPIOID DEPENDENT CLIENTS CG/pain management in opioid dependency/03/15 Policy Type Clinical Guideline Electronic File/Location
More informationMedication Reviews within Care Homes. Catherine Armstrong
Medication Reviews within Care Homes Catherine Armstrong What is a Medication Review? A structured, critical examination of a patient s medicines with the objective of reaching an agreement with the patient
More informationAnticholinergic (Antimuscarinic) Guidelines. Treatment of Antipsychotic Induced Extra Pyramidal Side Effects (EPSE)
Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire West Primary Care Alliance Anticholinergic (Antimuscarinic)
More informationGuidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care
Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia
More information1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA
UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical
More informationAnalgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
More informationPharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007
Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual
More informationPrescribing Drugs to the Elderly
Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering
More informationRatified by: Care and Clinical Policies Date: 17 th February 2016
Clinical Guideline Reference Number: 0803 Version 5 Title: Physiotherapy guidelines for the Management of People with Multiple Sclerosis Document Author: Henrieke Dimmendaal / Laura Shenton Date February
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE
More informationOctober 2009 CE Site code #107200E-1209
October 2009 CE Site code #107200E-1209 The Patient with an Altered Mental Status Outline prepared by: Jeremy Lockwood FFPM Mundelein Fire Department Material reviewed and revised by Sharon Hopkins, RN,
More informationSpecialist Palliative Care Service Referral Criteria and Guidance
Specialist Palliative Care Service Referral Criteria and Guidance Specialist Palliative Care Service Referrals These guidelines cover referrals for patients with progressive terminal illness, whether
More informationInterface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE
Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable
More informationAPOMORPHINE (Adults) Shared Care Guidelines DRUG:
Shared Care Guidelines DRUG: APOMORPHINE (Adults) Indication: Treatment of motor fluctuations in patients with Parkinson's disease which is not sufficiently controlled by oral anti-parkinson medication.
More informationAcute management of in-patient Parkinson s Disease patients
Acute management of in-patient Parkinson s Disease patients Contents Pages Introduction and Admission advice 2 Nil by Mouth Guidance 3 5 Complex therapy advice (Apomorphine, DBS, Duodopa) 6 Surgical peri-operative
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationFormulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services DRIVING AND MENTAL HEALTH CONDITIONS AND TREATMENTS General information Driving while impaired by a physical
More informationFormulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services VIOLENCE, AGGRESSION OR SEVERE BEHAVIOURAL DISTURBANCE Introduction During an acute episode or illness, some
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More informationUpdates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use
Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Stephen Eide R. Ph Oni Kinberg LCSW, MSSW Updates to the SOM On March 25, 2016 CMS sent out updates
More informationFrom MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018
From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018 Overview What is dementia? Common causes Normal cognitive decline Abnormal decline and mild cognitive impairment How do we manage dementia Can
More informationCritical Care Pharmacological Management of Delirium
Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Specific needs of patients with chronic disease Drug Nutrient interactions R. Witkamp (NL) Drug Nutrient interactions Prof dr. Renger Witkamp Nutrition and Pharmacology @rengerwitkamp
More informationWednesday September 20 th CMT Regional Study Day. Dr Colin Mason, Consultant DME, Addenbrooke s Hospital
Wednesday September 20 th CMT Regional Study Day Dr Colin Mason, Consultant DME, Addenbrooke s Hospital Develop a structured approach to a patient presenting with a fall Risk stratify who can go home and
More informationPATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE
SCHEDULING STATUS: S5 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: ZOXADON 0,5 mg: Each tablet contains 0,5 mg risperidone. ZOXADON 1 mg: Each tablet contains 1 mg risperidone. ZOXADON 2 mg: Each
More informationMISCELLANEOUS AGENTS - ALPHA-AGONISTS
Documentation A. FDA Approved Indications ADHD (Clonidine, Guanfacine) Documentation B. Non-FDA approved, commonly used psychiatric indications 1. Alcohol and opiate dependence 2. Opioid withdrawal 3.
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationIntegrated Care Pathway (ICP) for the. Management of clozapine INPATIENT INITIATION
Document Reference MM 048 Integrated Care Pathway (ICP) for the Management of clozapine INPATIENT INITIATION Surname Title Address Forenames Date of Birth RT/NHS number Care Co-ordinator GP CS number Consultant
More informationINSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4
INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep
More informationTreatments for migraine
Treatments for migraine Information for patients and carers Department of Neurology Aberdeen Royal Infirmary Contents Page About this leaflet Abortive medication for migraine Painkillers Antisickness medication
More informationPreventing falls in hospitals Where to start? Dr Frances Healey November 2013
Preventing falls in hospitals Where to start? Dr Frances Healey November 2013 Semi-United Kingdom Timeline of national initiatives 2007 2008 2009 2010 2011 2012 2013 National Reporting & Learning System
More informationPrimary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA
Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients Danielle Hansen, DO, MS (Med Ed), MHSA Clinical Assistant Professor, LECOM Associate Director, LECOM Institute for Successful
More informationSHARED CARE PROTOCOL CHOLINESTERASE INHIBITORS IN ALZHEIMER S DEMENTIA
SHARED CARE PROTOCOL CHOLINESTERASE INHIBITORS IN ALZHEIMER S DEMENTIA Introduction Alzheimer s disease is the most common cause of dementia. It is characterised by an insidious onset of global mental
More informationREFERRAL GUIDANCE COMMUNITY DENTAL SERVICES. Version 1: From April 2015 onwards.
REFERRAL GUIDANCE COMMUNITY DENTAL SERVICES Version 1: From April 2015 onwards. INTRODUCTION The remit of Bridgewater Community Dental Services is to provide the following services: Adult and Children
More informationWhat is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
More informationMANAGEMENT OF PATIENTS WITH PARKINSON S DISEASE WHO ARE NIL BY MOUTH OR WITH A COMPROMISED SWALLOW
MANAGEMENT OF PATIENTS WITH PARKINSON S DISEASE WHO ARE NIL BY MOUTH OR WITH A COMPROMISED SWALLOW Author: Gordon W Duncan Status: Approved Authorised by: Clinical Policy Group Version: 1.0 Review date:
More informationClinical. High Dose Antipsychotic Prescribing Procedures. Document Control Summary. Contents
Clinical High Dose Antipsychotic Prescribing Procedures Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationFall Risk Assessment and Management. Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007
Fall Risk Assessment and Management Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007 Slide 2 OBJECTIVES Know and understand: The importance of falls by older persons
More informationSiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]
SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm
More informationGuidance on Consent to Treatment Documentation for Medication Patient s Detained under the Mental Health Act
Guidance on Consent to Treatment Documentation for Medication Patient s Detained under the Mental Health Act This guidance is intended for Coventry and Warwickshire Partnership Trust staff to use when
More informationBrain and Central Nervous System Cancers
Brain and Central Nervous System Cancers NICE guidance link: https://www.nice.org.uk/guidance/ta121 Clinical presentation of brain tumours History and Examination Consider immediate referral Management
More informationParkinson s Disease. Gillian Sare
Parkinson s Disease Gillian Sare Outline Reminder about PD Parkinson s disease in the inpatient Surgical patients with PD Patients who cannot swallow End of life care Parkinson s disease PD is the second
More informationA Step Forward: Promoting Independence through Falls Prevention
A Step Forward: Promoting Independence through Falls Prevention 2014 Geriatric Update Meharry Consortium Geriatric Education Center A Step Forward: Promoting Independence through Falls Prevention Moderator:
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationFALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C
FALLS PREVENTION S H I R L E Y H U A N G, M S c, M D, F R C P C S T A F F G E R I A T R I C I A N T H E O T T A W A H O S P I T A L B R U Y E R E C O N T I N U I N G C A R E W I N C H E S T E R D I S T
More informationNHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain
NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Carbamazepine For the Treatment of Pain This information is not intended to replace your doctor s
More informationCommunity and Mental Health Services. Palliative Care. Criteria and
Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients
More informationDementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP
Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia
More informationS H A R E D P R E S C R I B I N G G U I D E L I N E
S H A R E D P R E S C R I B I N G G U I D E L I N E Introduction This shared prescribing guideline for the second generation antipsychotic medications listed above has been developed with due consideration
More informationSHARED CARE GUIDELINE
SHARED CARE GUIDELINE Methylphenidate in the treatment of Attention Deficit Hyperactivity Disorder in Children, Young People and Adults Implementation Date: June 2015 Review Date: June 2017 This guidance
More informationMIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam
MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet
More information